Free Trial
NASDAQ:BLFS

BioLife Solutions Q2 2026 Earnings Results & Report

BioLife Solutions logo
$38.61 0.00 (0.00%)
As of 11/6/2026

BioLife Solutions beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 6, 2026. The company reported EPS of $0.91 versus the $0.0313 consensus estimate, while revenue of $28.47 million topped the $27.80 million estimate by $670.00 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes
Conference Call
4:00 PM ET

BioLife Solutions EPS Results

Actual EPS
$0.91
Consensus EPS
$0.0313
Beat/Miss
Beat by +$0.8788
One Year Ago EPS
N/A
EPS Beat Rate
7 of last 8 quarters

BioLife Solutions Revenue Results

Actual Revenue
$28.47 million
Expected Revenue
$27.80 million
Beat/Miss
Beat by +$670.00 thousand
YoY Revenue Growth
N/A

BioLife Solutions Q2 2026 Earnings FAQ

BioLife Solutions (NASDAQ:BLFS) reported earnings of $0.91 per share for Q2 2026, beating the consensus estimate of $0.0313. The report was announced on Thursday, August 6, 2026.

BioLife Solutions reported revenue of $28.47 million for Q2 2026, against a consensus estimate of $27.80 million.

BioLife Solutions Earnings Headlines

BioLife Solutions (BLFS) Set to Post Quarterly Earnings on Thursday
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
BioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P 1000
See More BioLife Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioLife Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioLife Solutions and other key companies, straight to your email.

About BioLife Solutions

BioLife Solutions (NASDAQ:BLFS) develops and supplies products and services used in the development and commercial production of cell and gene therapies and other biologic medicines. Its offerings support the handling, preservation, storage and distribution of sensitive biological materials.

The company’s products include CryoStor and HypoThermosol preservation media, as well as CellSeal bags designed for cryogenic storage. BioLife also provides temperature-controlled storage and repository services for biological materials through its SciSafe business.

BioLife has expanded beyond its roots in biopreservation products to offer a broader portfolio for biopharmaceutical and life sciences customers. It serves customers in the United States and internationally, including therapy developers, biopharmaceutical companies and research organizations.

View BioLife Solutions Profile